SA
TRAX logo
First Tracks Biotherapeutics Inc(TRAX)
Closing price · checked 4:14 PM ETAbout this dataData status
$41.64▼-2.82 (-6.34%)
Extended:$41.64+0.00 (+0.00%)· 4:14 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

First Tracks Biotherapeutics Inc (TRAX)

R&D to Revenue

0.00%

Fiscal year · Period ending:

TRAX logo

TRAX R&D to Revenue

Latest reported0.00%
TRAX FY R&D/Revenue (0.00% → 0.00%)
Powered by
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

TRAX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

First Tracks Biotherapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to RevenueChange
0%0.00 pts
0%0.00 pts
0%—

Frequently asked questions: TRAX r&d to revenue

What is First Tracks Biotherapeutics Inc (TRAX)'s current r&d to revenue?

First Tracks Biotherapeutics Inc (TRAX)'s latest reported r&d to revenue (Fiscal year) is 0.00% as of Dec 31, 2025. R&D spending as percentage of revenue.

How much historical r&d to revenue data is available for TRAX?

Stock Alarm Pro provides 3 dated annual fiscal periods observations for First Tracks Biotherapeutics Inc (TRAX)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare TRAX's r&d to revenue to peers or set an alert?

You can open TRAX's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on TRAX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.